CD8A and COVID-19: Findings from studies on CD8+ memory T cell responses to vaccination showed that approximately 70%–90% of people exhibited spike-specific CD8+ T cell responses weeks after receiving two doses of an mRNA vaccination for COVID-19, and memory CD8+ T cells were found in 41%-65% of people six months following the second dosage (7 months from first dose) [35,36].